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Abstract 
BACKGROUND: Many patients who are candidates for a pacemaker are also at the same time risk factors for 
coronary artery disease such as high blood pressure, hypertension, diabetes, and hyperlipidemia, and therefore 
the probability of having coronary artery disease is significant. Effective diagnostic measures can be taken to 
prove the factors affecting the incidence of CAD in patients undergoing pacemakers at high-risk, including 
angiography. Therefore, it can prevent complications during and after pacemaker implantation, which leads to an 
increase in the quality of treatment in patients requiring pacemaker implantation.  
AIM: Therefore, the purpose of this study was to determine the predictive factors of significant coronary artery 
disease in patients with pacemaker implantation to identify patients in need of coronary angiography at the time of 
pacemaker implantation. 
METHODS: This retrospective study was carried out to examine the patients' files that were placed at the heart of 
Imam Reza Hospital during the period between March 2017 and September 2017. Demographic data, risk factors, 
echocardiography findings, and angiography, were collected and then recorded using a checklist. Statistical 
analysis was performed using SPSS software version 22 and Chi-square, and Mann-Whitney tests were used for 
determining significates variables.  
RESULTS: A group of 102 patients who had undergone a permanent cardiac pacemaker insertion due to an 
atrioventricular (AV) Block were included in the study, and also coronary anatomy was determined coronary 
angiography. Based on the results, 13.7% of patients with cardiac pacemaker had obstructive coronary artery 
disease (stenosis > 70%). Factors affecting coronary artery stenosis on angiography include gender, chest pain, 
history of myocardial infarction, angioplasty, diabetes, smoking, history of aspirin intake, calcium blocker and 
Plavix, high hematocrit, ST elevation and ST depression in the ECG, and severe mitral regurgitation.  
CONCLUSION: It seems that in most patients requiring permanent pacemaker insertion because of the 
atrioventricular (AV) Block, angiography does not change the patient's fate, and so can be ignored. However, in 
patients who have several risk factors from the listed above, coronary angiography is recommended during 
admission. 
 
 
 
 
 
 
Introduction 
 
Coronary Artery Disease (CAD) is the leading 
cause of death in industrialised countries [1]. In 
addition to its impact on mortality rates, CAD also 
causes disability and reduced productivity [2]. Over 
the past few decades, with the advancement of CAD 
diagnosis, prevention and treatment, and the mortality 
rate of this disease has decreased. However, in the 
United States alone, about 1.2 million cases of 
myocardial infarction or fatal heart attacks occur 
annually [3]. Nearly half of all deaths in industrialised 
countries and 25% of deaths occur in developing 
countries due to coronary artery disease [4]. By 2020, 
the number of deaths expected to exceed the number 
of deaths from infectious diseases [5]. 
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Many patients who are candidates for 
pacemakers have a simultaneous risk factor for 
coronary artery disease, such as high age, 
hypertension, diabetes, hyperlipidemia; so, the 
probability of having coronary artery disease is 
significant, with a 30% risk [6], [7]. 
Also, many patients with bradyarrhythmias, 
especially the atrial fibrillation block, have symptoms 
such as chest pain and shortness of breath that 
overlaps with the symptoms of coronary artery 
disease, and at the same time, patients may suffer 
from acute coronary syndrome and bradycardia of the 
heart [8], [9]. Finally, the pacemaker insertion can be 
implemented in the cardiac catheterisation room, 
where there is the possibility of performing coronary 
angiography simultaneously. However, coronary 
angiography is not routinely found to indicate in 
patients with Bradyarrhythmia. 
However, if the prediction of patients with 
significant coronary artery disease is performed, 
coronary angiography can also be done concurrently 
with pacemaker insertion and identified the presence 
and severity of coronary artery disease. Additionally, 
coronary angiography can be avoided in unnecessary 
cases, which is an invasive procedure with inherent 
complications, especially in older patients [12]. 
Effective diagnostic measures including 
angiography can be performed by proving the factors 
influencing the incidence of CAD in high-risk patients 
who undergo pacemaker implantation to prevent 
complications during and after placement of the 
pacemaker and to increase the quality of therapy in 
patients requiring pacemakers. Several studies have 
investigated the location of coronary artery 
involvement in patients with heart block, or have 
examined the effect of revascularization on the 
removal of the heart block removal and the 
implantation of a permanent pacemaker [6], [7], [8], 
[13], [14], [15]. 
Therefore, the current study was aimed to 
evaluate factors associated with coronary artery 
disease in patients with pacemakers, which can help 
choose patients who simultaneously require coronary 
angiography. 
 
 
Material and Methods 
 
This retrospective study was carried out using 
the medical record of all patients who had permanent 
pacemaker implantation from the beginning of March 
2017 to September 2017 at the cardiology 
department, Imam Reza Hospital of Mashhad 
University of Medical Sciences. The coronary 
anatomy of patients was determined by angiography 
during admission or at least one month before or after 
the pacemaker insertion, and then subjects were 
included in the study. The location and extent of 
involvement for all coronary arteries and their 
branches were determined by the cardiologist via 
examining the angiographic film, or according to 
available and reliable written reports. 
Based on the results of coronary artery 
angiography, patients were divided into two groups. 
The first group was patients with significant coronary 
artery disease. (There is at least one vessel involved 
with stenosis of up to 70% in a major vessel or in the 
main branch of a vessel that needs revascularisation). 
Group 2: Patients with no significant coronary artery 
involvement. 
The variables studied included: Age, sex, 
BMI, diabetes, hypertension, dyslipidemia, smoking, 
serum troponin levels, CK and CK-MB, symptoms in 
referral time (syncope, chest pain, dyspnea), serum 
creatinine, left ventricular ejection fraction (LVEF), 
Mitral valve failure, pulmonary artery pressure, 
coronary calcification in fluoroscopy during pacemaker 
implantation, mitral annular calcification in fluoroscopy 
or echocardiography, cause of pacemaker 
implantation. 
 
Statistical analysis 
Data from patients' demographic and clinical 
observations were analysed using SPSS software 
version 22. To describe the data, descriptive statistical 
methods, including central indicators, distribution, and 
frequency, were employed. T-test or its nonparametric 
equivalents were used to compare quantitative 
variables in two independent groups. Furthermore, the 
Chi-square test was applied to compare qualitative 
variables in two groups. In all tests, p < 0.05 was 
considered as a significant level. 
 
 
Results 
 
This study was performed on 102 patients 
under coronary angiography and pacemaker insertion. 
Among all enrolled subjects, 53 (52%) men and 49 
(48%) women were present. In this study, individuals 
with permanent pacemaker implantation were 
searched form the medical records, and people who 
had coronary angiography were also examined. Also, 
subjects who included both of the measures 
mentioned above were enrolled in the study. The 
mean age of the patients was determined as 71.25 ± 
11.32 year, and the patients were in the range of 44 to 
93 years old. Among all 102 enrolled patients, 88 
(86.3%) were not found to suffer from coronary artery 
disease, and 14 (13.7%) had coronary artery 
involvement. 
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Table 1: Average and frequency of demographic and clinical 
variables in patients with pacemaker implantation based on 
coronary artery involvement 
Coronary artery disease / Disorder No Yes Total P-value 
Age(year) 1717  ±   77111  12127±1177 17127±7711 31111 
Sex (1117 )%77  (2212 )%72  (73313 )%71  31331 3.008 
(9719 )%71  (717 )%2  (73313 )%79   
Smoking (1211 )%72  (2111 )%2  (73313 )%22  31311 
Type of 
referral 
symptoms 
(1911 )%73  (7311 )%2  (73313 )%72  31111 0.787 
(1117 )%17  (7217 )%7  (73313 )%73   
Type of 
referral 
symptoms 
(1911 )%71  (7312 )%2  (73313 )%79  31371 0.047 
(9717 )%27  (717 )%7  (73313 )%22   
(2211 )%73  (1111 )%7  (73313 )%77   
(73313 )%2  3 (73313 )%2   
Underlying 
disease 
(7313 )%7  (7313 )%7  (73313 )%1  31372 0.012 
(7313 )%7  (7313 )%7  (73313 )%2  31271 0.257 
(2313 )%7  (1313 )%7  (73313 )%7  31337 0.001 
(73313 )%2  3 (73313 )%2  7 7 
(73313 )%7  3 (73313 )%7  7 7 
(2113 )%71  (1213 )%1  (73313 )%27  31337 0.005 
(1119 )%72  (7217 )%73  (73313 )%22  3111 0.38 
(1713 )%77  (2713 )%7  (73313 )%23  31732 0.102 
(1717 )%22  (7117 )%7  (73313 )%21  31199 0.399 
 
As shown in Table 1, no significant difference 
was found in the mean and standard deviation of age 
in patients with pacemaker implantation based on 
coronary artery involvement (P > 0.05). However, the 
frequency of coronary artery disease in men was 
significantly higher than that of women (22.6% vs 
4.1%) (P = 0.008). The frequency of coronary artery 
disease in patients with cigarette smoking was 
significantly higher as compared to non-smokers 
(27.3% vs 10%), (P < 0.05). Also, the frequency of 
referral type in patients with pacemaker implantation, 
based on coronary artery disease, was not 
significantly different (P > 0.05). Moreover, the 
incidence of coronary artery disease in patients with 
chest pain was significantly higher when compared 
with other patients (33.3%) (P = 0.47). 
Frequency of coronary artery disease in 
patients with myocardial infarction (50% versus 
10.6%), angioplasty (80% vs 10.3%) and diabetes 
(32% versus 7.8%) was significantly higher than other 
patients without aspects (P < 0.05). 
Table 2: Frequency of medication use in patients with 
pacemaker implantation based on coronary artery involvement 
Coronary artery disease / Drug No Yes Total P-value 
Beta blocker No Number 77 7 71 
31712 
Percent 9711%  111%  73313%  
Yes Number 77 73 77 
Percent 1717%  7117%  73313%  
Digoxin No Number 12 77 733 
31729 
Percent 1213%  7713%  73313%  
Yes Number 2 3 2 
Percent 73313%  313%  73313%  
Aspirin No Number 21 1 22 
31337 
Percent 9717%  717%  73313%  
Yes Number 27 77 12 
Percent 2917%  1312%  73313%  
Calcium blocker No Number 72 7 27 
31371 
Percent 9711%  112%  73313%  
Yes Number 12 9 77 
Percent 1113%  2213%  733%1  
Plavix No Number 11 1 97 
<31337 
Percent 9712%  117%  73313%  
Yes Number 7 2 1 
Percent 7711%  1711%  73313 
 
The frequency of coronary artery disease in 
patients with history of aspirin use (30.6% vs. 4.5%), 
calcium blocker (22% vs. 8.2%) and Plavix (85.7% vs. 
8.4%) %) was significantly higher as compared to 
other patients without the history of using the drugs 
(Table 2). 
Table 3: Mean and standard deviation of laboratory variables of 
patients with pacemakers based on coronary artery 
involvement 
Variable  No Yes P-value 
FBS 737132±77172 73117±12122 31117 
Cr 7137±3171 7177±3177 31731 
Na 719191±9191 711127±2132 31211 
K 7111±3177 7111±3179 31177 
Ca 1117±3112 9±3177 31231 
Uric Acid 1219±1177 12131±1197 31137 
CTn.1 31337±31371 31311±3137 31772 
CTn.2 313331±31337 3 31127 
Chol 772127±17127 771121±11111 31127 
TG 771177±29111 777129±71121 31121 
LDL 73117±1312 732177±71171 31172 
HDL 72±111 19±1121 31277 
WBC 1177±7127 1122±7129 31237 
RBC 712±7139 7117±3121 31212 
Hgb 71171±1122 71191±7172 31729 
Hct 73177±1121 77112±211 31372 
MCV 19117±27112 11127±2131 31979 
Plt 233117±77112 231117±29117 31772 
LDL (Low-density lipoprotein), HDL (High –density lipoprotein ;RBC (Red blood cell), WBC 
(White blood cell); MCV (mean cell volume). 
 
As indicated in Table 3, the only hematocrit in 
patients with coronary artery disease was significantly 
higher compared with patients without coronary artery 
disease (41.72 vs 40.15) (P = 0.42). 
Table 4: Frequency of ECG abnormalities in patients with 
pacemaker implantation based on coronary artery involvement 
Coronary artery disease   / Disorder No Yes Total P-value 
AF No Number 17 71 91 
154.0 
Percent 1211%  7111%  73313%  
Yes Number 1 7 7 
Percent 1713%  2713%  73313%  
AT No Number 11 71 737 
150.0 
Percent 1117%  7219%  73313%  
Yes Number 3 7 7 
Percent 313%  73313%  73313%  
AVB 2 No Number 11 77 737 
0 
Percent 1217%  7119%  73313%  
Yes Number 7 3 7 
Percent 73313%  313%  73313%  
AVB 2.1 No Number 21 72 19 
150.0 
Percent 1711%  7712%  73313%  
Yes Number 27 2 21 
Percent 9711%  111%  73313%  
CAVB No Number 27 2 21 
15200 
Percent 9212%  117%  73313%  
Yes Number 21 72 17 
Percent 1713%  7213%  73313%  
RBBB No Number 17 71 17 
154.4 
Percent 1717%  7717%  73313%  
Yes Number 71 7 71 
Percent 9717%  712%  73313%  
LBBB No Number 21 77 19 
15904 
Percent 1217%  7119%  73313%  
Yes Number 23 1 21 
Percent 1113%  7113%  73313%  
Narrow QRS No Number 71 73 71 
15204 
Percent 1211%  7112%  73313%  
Yes Number 73 7 77 
Percent 9319%  917%  73313%  
No Intrinsic QRS No Number 11 77 737 
0 
Percent 1217%  7119%  73313%  
Yes Number 7 3 7 
Percent 73313%  313%  73313%  
ST Elevation No Number 17 2 11 
<15110 
Percent 9117%  219%  73313%  
Ant Number 7 1 7 
Percent 2713%  1713%  73313%  
Inf Number 3 7 7 
Percent 313%  73313%  73313%  
Lat Number 7 3 7 
Percent 73313%  313%  73313%  
ST Depression No Number 12 9 97 
<15110 
Percent 9317%  919%  73313%  
Ant Number 3 7 7 
Percent 313%  73313%  73313%  
T wave Inversion No Number 19 71 92 
150.2 
Percent 1719%  7717%  73313%  
Inf Number 2 3 2 
Percent 73313%  313%  73313%  
Lat Number 7 3 7 
Percent 73313%  3313%  73313%  
AF (Atrial fibrillation); AVB (Atrioventricular block); CAVB (Complete atrioventricular block); 
RBBB (Right bundle branch block); LBBB (Left bundle branch block). 
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According to Table 4, the incidence of 
coronary artery disease in patients with ST-segment 
elevation was significantly lower in the lower wall 
(100%) and the front wall (75%) than in other patients 
(P < 0.001). Furthermore, the frequency of coronary 
artery disease in patients with ST-segment depression 
in the front part (100%) was significantly higher as 
compared to patients without ST-segment depression 
(p < 0.001). 
Table 5: Frequency of angiographic impairment in patients with 
pacemaker implantation based on coronary artery involvement 
Coronary artery disease   / Angiography No Yes Total P-value 
Vessels involved in 
angiography 
No Number 17 3 17 
<31337 
Percent 9111%  313%  1712%  
LM Number 3 7 7 
Percent 313%  2112%  713%  
LAD Number 7 7 7 
Percent 717%  2112%  713%  
LCX Number 3 7 7 
Percent 313%  117%  713%  
OM Number 7 3 7 
Percent 717%  313%  713%  
RCA Number 3 7 7 
Percent 313%  2112%  713%  
PLV Number 3 7 7 
Percent 313%  117%  713%  
Angioplasty after 
angiography 
No Number 12 2 92 
<31337 
Percent 9111%  7219%  9312%  
Yes Number 2 1 73 
Percent 211%  7117%  911%  
 
CABG after 
angiography 
No Number 11 72 733 
31371 
Percent 73313%  1711%  9113%  
Yes Number 3 2 2 
Percent 313%  7711%  2313%  
LM (Left main artery); LAD (Left anterior descending artery); LCX (Left circumflex artery) 
OM(Obtuse marginal); RCA (Right coronary artery) PLV (Posterior left ventricular). 
 
As summarised in Table 5, the most involved 
vessels in the patients simultaneously included LM, 
LAD, and RCA (each of 28.6%). Also, patients 
experienced angioplasty after angiography (57.1%), 
and CABG after angiography (14.3%).  
Regarding the results presented in Table 6, patients 
with severe mitral regurgitation (100%) had coronary 
artery disease after implantation of the pacemaker (P 
< 0.05). 
Table 6: Frequency of echocardiography in patients with 
pacemaker implantation based on coronary artery involvement 
Coronary artery disease  
 Echocardiography 
No Yes Total P-value 
Mitral 
insufficiency 
No Number 27 2 21 
1511. 
Percent 9713%  913%  73313%  
Mild Number 72 7 71 
Percent 9717%  719%  73313%  
Moderate Number 7 1 1 
Percent 2217%  1117%  73313%  
Severity Number 3 7 7 
Percent 313%  73313%  73313%  
Mitral annulus 
calcification 
No Number 12 77 91 
1502. 
Percent 1112%  7711%  73313%  
Yes Number 3 7 7 
Percent 313%  73313%  73313%  
Tricuspid 
insufficiency 
No Number 72 7 72 
1502. 
Percent 9219%  117%  73313%  
Mild Number 27 7 27 
Percent 1713%  7213%  73313%  
Moderate Number 2 1 9 
Percent 2211%  1111%  73313%  
Severity Number 1 7 7 
Percent 1713%  2713%  73313%  
Aortic valve 
position 
Normal Number 11 73 11 
15020 
Percent 1113%  7213%  73313%  
Calcification Number 7 3 7 
Percent 73313%  313%  73313%  
Failure Number 1 2 73 
Percent 1313%  2313%  73313%  
 
 
Discussion 
 
Many patients who are candidates for 
pacemaker implantation, due to the atrioventricular 
(AV) Block, have high age and at the same time are at 
risk for coronary artery disease. Coronary artery 
blockage can be an etiological factor in the 
impairment of the cardiac conduction system and 
require the use of a pacemaker. On the other hand, in 
patients requiring pacemakers, non-invasive tests, 
such as exercise tests, are not possible for diagnosis 
of coronary artery disease, or their diagnostic value is 
lower than other patients [18], [16]. Therefore, the 
study of factors associated with coronary artery 
disease in these patients can help choose patients 
who simultaneously need coronary angiography. 
This study was performed on 102 patients 
with pacemaker implantation. Among all included 
patients, 53 (52%) were men, and 49 (48%) were 
women. The mean age of the patients was calculated 
to be 71.11 ± 25.32 years old, and the patients were 
in the range of 44 to 93 years old. Of the 102 patients 
who were admitted, 88 (86.3%) were without coronary 
artery disease, and 14 (13.7%) had coronary artery 
disease. Based on the result presented herein, the 
mean and standard deviation of age, frequency of f 
referral type in patients with pacemaker implantation 
based on coronary artery involvement was not found 
to be significantly different (P > 0.05). However, it was 
found that the frequency of coronary artery disease in 
men was significantly higher as compared to women 
(22.6% vs 4.1%). The findings revealed that the 
frequency of coronary artery disease in patients with 
chest pain was significantly higher while comparing 
with other patients (33.3%). Frequency of coronary 
artery disease in patients with myocardial infarction 
(50% versus 10.6%), angioplasty (80% vs 10.3%) and 
diabetes (32% versus 7.8%) was significantly higher 
than other patients without aspects (P < 0.05). 
However, other diseases did not have a significant 
relationship with the incidence of coronary artery 
disease. The frequency of coronary artery disease in 
patients with cigarette smoking was remarkably higher 
than non-smokers (27.3% vs 10%). The frequency of 
coronary artery disease in patients with a history of 
aspirin use (30.6% vs 4.5%), calcium blocker (22% vs 
8.2%) and Plavix (85.7% vs 8.4%) %) was markedly 
higher as compared to other patients without the 
history of using the drugs. Regarding laboratory 
variables, it was found that only hematocrit in patients 
with coronary artery disease was significantly higher 
in comparison with patients without coronary artery 
disease.  
Our findings demonstrated that the incidence 
of coronary artery disease in patients with ST-
segment elevation was significantly lower in the lower 
part (100%) and the front part (75%) as compared to 
in other patients. The frequency of coronary artery 
disease in patients with ST-segment depression in the 
front part (100%) was found to be remarkably 
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increased as compared to patients without ST-
segment depression.  
The findings indicated that the most involved 
vessels in the patients simultaneously included LM, 
LAD, and RCA (each of 28.6%). Furthermore, patients 
experienced angioplasty after angiography (57.1%), 
and CABG after angiography (14.3%).  
Regarding the results presented in Table 6, 
patients with severe mitral regurgitation (100%) had 
coronary artery disease after implantation of the 
pacemaker. In a study conducted by Brueck et al., in 
2008, investigated the incidence of coronary artery 
disease in pacemaker insertion in 507 patients, where 
212 (42%) with permanent pacemakers underwent 
coronary angiography with two months before or after 
the pacemaker insertion. They indicated that severe 
conduction disturbances or sinus node dysfunction 
could probably be associated with CAD, where 
myocardial revascularisation is needed. In this study, 
diabetes and hypercholesterolemia were predictors of 
coronary artery disease. The data show that patients 
with severe conduction disturbances or sinus node 
dysfunction have coronary artery disease, with at least 
one risk factor for atherosclerosis [5]. 
Based on the data presented herein, out of 
102 cases, 88 cases (86.3%) were without the 
involvement, and 14 (13.7%) had coronary artery 
disease, which is much lower than study above. The 
reason for this difference may be due to the sample 
size and sampling methods, patient demographics, 
inclusion, and exclusion criteria. The study mentioned 
above-demonstrated diabetes as a cause of coronary 
artery disease, which was in concurrence with our 
observations. 
Another study by Alai et al. was conducted to 
examine the incidence of coronary artery disease in 
patients requiring pacemaker implantation. They 
indicated that 45% of patients showed CAD, of which 
29% revealed obstructive CAD, reaming 16% 
exhibited non-obstructive CAD. Furthermore, 53.3% of 
patients revealed SVD, followed by DVD (15.6%) and 
TVD (31.1%).  
Type I (6.9%), II (34.5%), III (10.3%), and IV 
(48.3%) coronary anatomies were found in enrolled 
subjects. The presence of CAD is linked to the history 
of smoking, dyslipidemia, and family history of CAD. 
CAD angiography has been found in most subjects 
with symptomatic bradyarrhythmias and risk factors 
for CAD, as reported by Alai et al. 
It can be said that such patients should 
undergo coronary monitoring before undergoing 
pacemaker surgery. Simultaneous CAD treatment is 
likely to improve the long-term prognosis of these 
patients [19]. The findings of the mentioned study on 
coronary artery disease are more than our study. 
Regarding effective risk factors, only smoking had a 
significant correlation with coronary artery disease. 
The reason for this difference may be due to the 
difference in the sample size, the difference in patient 
demographics, the difference in the sampling method 
and inclusion and exclusion criteria, as well as leaving 
the study. However, similar to our study, it was found 
that diabetes is a factor in the incidence of coronary 
artery disease. 
Hsueh et al. investigated the incidence of 
coronary artery disease and its risk factors in patients 
requiring pacemakers. They found the following 
results: Regarding coronary angiography, the 
incidence rate of CAD has been determined as 20%. 
The node-related artery was rarely seen 
among CAD patients with symptomatic 
bradyarrhythmia (9%), and the majority of subjects 
showed stenosis for LAD (74%). The baseline 
features and symptoms presented in patients with or 
without CAD were not statistically different.  
Hypercholesterolemia and DM were found to 
be two independent predictors of CAD. Finally, it was 
concluded that hypercholesterolemia and DM were 
one of the most important predictors of CAD in these 
patients. 
 The node-related artery is rarely involved in 
patients with CAD and symptomatic bradyarrhythmia 
[14]. Meanwhile, in our study, it was found that 88 
patients (86.3%) had no coronary artery disease, and 
14 (13.7%) had coronary artery disease that was less 
than the study above. By our findings, it became clear 
that diabetes is a factor in the incidence of coronary 
artery disease. However, in contrast to the study, 
hypercholesterolemia in our study did not correlate 
with CAD incidence [14]. Ciaroni et al., investigate the 
incidence of coronary artery disease and its risk 
factors in patients requiring permanent transvenous 
pacemaker using dobutamine stress 
echocardiography, thallium-201 myocardial CT, and 
coronary arteriography during 8 days. None of these 
patients experienced myocardial infarction. Sixteen 
(55%) of patients was diagnosed as CAD in 
angiography. Diagnostic sensitivity for CAD was 
determined to be 94% for tomography and 88% for 
echocardiography, but this difference in CAD 
diagnosis was not found to be significant. 
Among 13 enrolled subjects without CAD, 9 
patients exhibited positive findings using tomography, 
where the specificity of 31% was achieved, on the 
other hand, one patient exhibited positive result based 
on the echocardiography, e.g., 92%. Therefore, 
dobutamine stress echocardiography was capable of 
increasing the rate of false-positive results in these 
patients and also maintains diagnostic sensitivity for 
CAD, consistent with myocardial tomography. In the 
study above, it was also found that male gender, 
diabetes, and positive family history were among the 
factors affecting the incidence of CAD in patients 
under pacemaker implantation (20). Meanwhile, our 
findings revealed that, among 102 included patients, 
88 (86.3%) patients didn’t show coronary artery 
disease, and 102 cases (13.7%) had coronary artery 
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disease, that was less than mentioned study The 
reason for this difference may be due to the sample 
size, demographic characteristics of the patients, the 
difference in the sampling method and inclusion and 
exclusion criteria and leaving the study. In line with 
our study, it appeared that diabetes and male gender 
were involved in the incidence of coronary artery 
disease. 
Regarding the fact that some factors are 
positive in predicting the incidence of coronary artery 
disease in patients with pacemaker therapy, it is 
possible to reduce complications and reduce 
hospitalisation time by performing coronary 
angiography in essential cases without 
implementation in unnecessary cases, thus leading an 
acceptable impact on cost and patient satisfaction. 
In conclusion, by proving the factors 
influencing the incidence of coronary artery disease in 
patients with pacemaker insertion can perform 
effective diagnostic procedures for high-risk patients, 
including angiography to prevent complications during 
and after pacemaker implantation and increase the 
quality of treatment in patients requiring a pacemaker. 
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